(AVES) Avantis Emerging Markets - Ratings and Ratios
Equities, Emerging Markets, Value
Dividends
| Dividend Yield | 3.71% |
| Yield on Cost 5y | 4.92% |
| Yield CAGR 5y | 81.49% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 14.4% |
| Value at Risk 5%th | 24.0% |
| Relative Tail Risk | 1.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.11 |
| Alpha | 12.72 |
| CAGR/Max DD | 0.88 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.426 |
| Beta | 0.585 |
| Beta Downside | 0.600 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.50% |
| Mean DD | 3.77% |
| Median DD | 3.06% |
Description: AVES Avantis Emerging Markets December 01, 2025
The Avantis® Emerging Markets Value ETF (AVES) seeks to allocate at least 80% of its assets to equity securities of companies operating in emerging-market economies, drawing its universe primarily from the MSCI Emerging Markets Value IMI Index. It is a U.S.–registered, diversified ETF that may hold stocks of any market-cap size across multiple sectors and countries, with the flexibility to invest in the full breadth of the index’s constituents.
Key data points to consider: the fund’s expense ratio is 0.35% and it manages roughly $1.2 billion in assets (as of Q3 2024); its weighted-average market capitalization is about $2.5 billion, reflecting a tilt toward mid-cap firms. The underlying index is heavily weighted toward financials (≈30%), consumer discretionary (≈20%) and commodities (≈15%), sectors that have historically benefited from the projected 4–5% real GDP growth across core emerging markets this year.
If you want a deeper, data-driven view of AVES’s valuation metrics and risk profile, a quick look at ValueRay’s analytical dashboard can help you spot any hidden upside or downside before you decide.
What is the price of AVES shares?
Over the past week, the price has changed by +0.31%, over one month by +0.64%, over three months by +1.23% and over the past year by +24.56%.
Is AVES a buy, sell or hold?
What are the forecasts/targets for the AVES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.3 | 18.8% |
AVES Fundamental Data Overview December 05, 2025
Beta = 1.04
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 854.7m USD (854.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 854.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 854.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.17% (E(854.7m)/V(854.7m) * Re(8.17%) + (debt-free company))
Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for AVES ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle